Genzyme's Fabrazyme Should Be Given in Full Dose, EU Says - Bloomberg
Links shared publicly online about this topic.
- 783total visits
Genzyme's Fabrazyme Should Be Given in Full Dose, EU Says - Bloomberg
Genzyme Corp.'s Fabrazyme drug for Fabry disease should be given in a full dose after patients receiving a lesser amount reported side effects, the European Medicines Agency said in an e-mailed statement. Patients also can be given a full dose of Shire Plc's Replagal, the agency said.
View full resource at bloomberg.com
Tags: Disease and Condition, Drug, Genzyme, Shire, disease, Medical
Most Recently Shared on October 22, 2010 at 11:20 am By:
Bloomberg: Genzyme’s Fabrazyme Should Be Given in Full Dose, EU Says. http://bit.ly/dawfCu
Advertisement
